These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18186888)

  • 1. The effect of glutamine supplementation on hematopoietic stem cell transplant outcome in children: a case-control study.
    Kuskonmaz B; Yalcin S; Kucukbayrak O; Cetin N; Cetin M; Tezcan I; Uckan D
    Pediatr Transplant; 2008 Feb; 12(1):47-51. PubMed ID: 18186888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study.
    Aquino VM; Harvey AR; Garvin JH; Godder KT; Nieder ML; Adams RH; Jackson GB; Sandler ES
    Bone Marrow Transplant; 2005 Oct; 36(7):611-6. PubMed ID: 16086046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: a prospective randomized study.
    Uderzo C; Rebora P; Marrocco E; Varotto S; Cichello F; Bonetti M; Maximova N; Zanon D; Fagioli F; Nesi F; Masetti R; Rovelli A; Rondelli R; Valsecchi MG; Cesaro S
    Transplantation; 2011 Jun; 91(12):1321-5. PubMed ID: 21499196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of oral glutamine in pediatric bone marrow transplant.
    Storey B
    J Pediatr Oncol Nurs; 2007; 24(1):41-5. PubMed ID: 17185401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of high-dose enteral glutamine on the incidence and severity of mucositis in paediatric oncology patients.
    Ward E; Smith M; Henderson M; Reid U; Lewis I; Kinsey S; Allgar V; Bowers D; Picton SV
    Eur J Clin Nutr; 2009 Jan; 63(1):134-40. PubMed ID: 17728695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.
    Schmid I; Stachel D; Pagel P; Albert MH
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):438-44. PubMed ID: 18342786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F; Diyachenko G; Zabelina T; Wolschke C; Fehse B; Bacher U; Erttmann R; Kröger N; Zander AR
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):913-9. PubMed ID: 18640575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the outcomes of children with acute myelogenous leukemia in either first or second complete remission (CR1 vs CR2) following allogeneic hematopoietic stem cell transplantation at a single transplant center.
    Gassas A; Ishaqi MK; Afzal S; Finkelstein-Shechter T; Dupuis A; Doyle J
    Bone Marrow Transplant; 2008 Jun; 41(11):941-5. PubMed ID: 18264141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the risk of transplant-related complications and individually tailoring the HSCT procedure in children and adolescents--is it possible?
    Faraci M; Dini G;
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S90-6. PubMed ID: 18978754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early (day -7) versus conventional (day -1) inception of cyclosporine-A for graft-versus-host disease prophylaxis after unrelated donor hematopoietic stem cell transplantation in children. Long-term results of an AIEOP prospective, randomized study.
    Lanino E; Rondelli R; Locatelli F; Messina C; Pession A; Balduzzi A; Favre C; Santarone S; Rabusin M; Pollichieni S; Cesaro S; Dini G;
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):741-8. PubMed ID: 19450759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low toxicity of a conditioning with 8-Gy total body irradiation, fludarabine and cyclophosphamide as preparative regimen for allogeneic hematopoietic stem cell transplantation in pediatric hematological malignancies.
    Yanagisawa R; Nakazawa Y; Sakashita K; Tanaka M; Shikama N; Kamijo T; Shiohara M; Koike K
    Pediatr Transplant; 2009 Sep; 13(6):737-45. PubMed ID: 19207225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parenteral glutamine supplementation has no effect on chemotherapy-induced toxicity in children with non-Hodgkin lymphoma.
    Yildirim ZK; Bidev D; Buyukavci M
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):371-6. PubMed ID: 23426005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomegalovirus infection in children undergoing hematopoietic stem cell transplantation in Chile.
    Paris C; Kopp K; King A; Santolaya ME; Zepeda AJ; Palma J
    Pediatr Blood Cancer; 2009 Sep; 53(3):453-8. PubMed ID: 19418548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parenteral nutrition in hematopoietic stem cell transplantation].
    Gómez Alvarez ME
    Farm Hosp; 2004; 28(2):116-22. PubMed ID: 15101803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
    Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
    Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
    Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.